Sun Pharmaceutical Industries Inc recalls Amphotericin B Liposome for Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Out of specification for assay
- Products
-
- Amphotericin B Liposome for Injection
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 11,016 vials
- About this recall
- Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-389350, Gujarat, India. NDC 62756-233-01